HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.140
+0.050 (1.62%)
At close: Jan 2, 2026, 4:00 PM EST
3.146
+0.006 (0.20%)
After-hours: Jan 2, 2026, 6:51 PM EST
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$578
Profits / Employee
-$602,426
Market Cap
9.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 15 | 0 | - |
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HSCS News
- 18 days ago - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - GlobeNewsWire
- 23 days ago - HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - GlobeNewsWire
- 4 months ago - HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results - GlobeNewsWire
- 5 months ago - HeartSciences Announces Conference Participation and Investor Webinar - GlobeNewsWire
- 5 months ago - HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results - GlobeNewsWire
- 7 months ago - HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - GlobeNewsWire
- 7 months ago - Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - GlobeNewsWire